¼¼°èÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2033³â)
Pancreatic and Biliary Stents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»óǰÄÚµå
:
1563076
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 09¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 245 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ÃÖ±Ù ¼¼°è ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¶»ç º¸°í¼¸¦ ¹ßÇ¥ÇßÀ¸¸ç, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇß½À´Ï´Ù. ÀÌ »ó¼¼ÇÑ º¸°í¼´Â ½ÃÀå ±¸Á¶¿Í ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀå °¡´É¼º¿¡ ´ëÇØ ¹àÇû½À´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ±Ô¸ð(2024³â) : 4¾ï 1,014¸¸ ´Þ·¯
¿¹Ãø ½ÃÀå ±Ô¸ð(2033³â) : USD 6¾ï 4,234¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2033³â±îÁö) : 5.1%
ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå : Á¶»ç ¹üÀ§
ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®´Â ÀϹÝÀûÀ¸·Î Á¾¾ç, ÃéÀå¿°, ´ã¼® µîÀÇ Áúº´À¸·Î ÀÎÇÑ ÃéÀå ¹× ´ãµµÀÇ Æó»öÀ» ¿ÏÈÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½ºÅÙÆ®´Â ´Ù¾çÇÑ ¼Òȱâ Áúȯ °ü¸®, ȯÀÚ ¿¹ÈÄ °³¼±, »îÀÇ Áú Çâ»ó¿¡ ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ´Â °ÍÀº ÃéÀ塤´ãµµ ÁúȯÀÇ À¯º´·ü Áõ°¡, ½ºÅÙÆ® ±â¼úÀÇ Áøº¸, ÀÌ·¯ÇÑ °Ç° ¹®Á¦¸¦ ¾È±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡ÀÔ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
¼¼°èÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ´Â ÁÖ¿ä ¿äÀÎÀº ¸î°¡Áö ÀÖ½À´Ï´Ù. ÃéÀå¾Ï ¹× ±âŸ ¼Òȱâ ÁúȯÀÇ ÀÌȯÀ²ÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀÌ ÇÊ¿äÇÏ¸ç ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³»½Ã°æ ¼ö¼úÀÇ Áøº¸¿Í ȯÀÚÀÇ Æí¾ÈÇÔ°ú È¿°ú¸¦ Çâ»ó½ÃŰ´Â Çõ½ÅÀûÀÎ ½ºÅÙÆ® ¼³°è ½ÃÀå °³Ã´ÀÌ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÁöÃâ Áõ°¡¿Í ³·Àº ħ½À óġ ÀÎÁöµµ Áõ°¡µµ ½ÃÀå È®´ë ÃßÁø¿¡ Å« ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
ÃéÀå°ú ´ãµµ ½ºÅÙÆ® ½ÃÀåÀº ¼ºÀåÀÇ °¡´É¼º¿¡µµ ºÒ±¸ÇÏ°í ¸î °¡Áö ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ½ºÅÙÆ® À¯Ä¡¿Í °ü·ÃµÈ ÇÕº´Áõ(À̵¿, Æó»ö µî)Àº ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í±Þ ½ºÅÙÆ® ±â¼úÀÇ ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ °³¹ß µµ»ó Áö¿ª¿¡¼ÀÇ »ç¿ëÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú ±¤¹üÀ§ÇÑ ÀÓ»ó °ËÁõÀÇ Çʿ伺µµ ½Å±Ô ÁøÃâ±â¾÷¿¡°Ô ½ÃÀå ÁøÀÔ À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ:
ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀåÀº ƯÈ÷ ¾ÈÀü¼º°ú È¿´ÉÀ» ³ôÀÌ´Â ½ºÅÙÆ® Àç·á¿Í µðÀÚÀÎÀÇ ±â¼ú Çõ½ÅÀÌ ÁøÇàµÇ°í Àֱ⠶§¹®¿¡ Å« ¼ºÀå ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¼Òȱ⠳»°ú¿¡¼ ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ ½ºÅÙÆ® À¯Ä¡ ¼Ö·ç¼Ç °³¹ß¿¡ »õ·Î¿î ±æÀ» ¿°í ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü¿Í ÀÇ·á Á¦°ø¾÷üÀÇ Çù¾÷Àº Á¦Ç° °³¹ßÀ» ÃËÁøÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ¼Òȱâ Áúȯ¿¡¼ °³ÀÎÈµÈ ÀÇ·á ¹× Ç¥Àû Ä¡·áÀÇ Ãß¼¼°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀÇ Ãß°¡ÀûÀÎ ±âȸ°¡ ¼³¸íµË´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
¼¼°èÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®°¡ °¡Àå ¸¹ÀÌ Ã¤¿ëµÇ°í ÀÖ´Â Áö¿ªÀº ¾îµò°¡, ¶Ç ¾î¶² µ¿ÇâÀÌ À̰Ϳ¡ ¿µÇâÀ» ÁÖ°í Àִ°¡?
³»½Ã°æ ±â¼úÀÇ ¹ßÀüÀº ½ºÅÙÆ® »ç¿ë°æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?
ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ±â¾÷Àº ´©±¸À̸ç, ½ÃÀå Æ÷Áö¼ÇÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶°ÇÑ Àü·«À» ½Ç½ÃÇϰí Àִ°¡?
¼¼°èÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå¿¡ ÀÖ¾î¼ÀÇ »õ·Î¿î µ¿Çâ°ú Àå·¡¼ºÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
Æ÷ÇÔ°ú Á¦¿Ü
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ
Á¦4Àå Áß¿äÇÑ ¼º°ø ¿äÀÎ
ÀýÂ÷ ä¿ë/»ç¿ë »óȲ ºÐ¼®
ÀýÂ÷ÀÇ USP/Ư¡
ÁÖ¿ä Á¦Á¶¾÷ü¿¡ ÀÇÇÑ ÇÁ·Î¸ð¼Ç Àü·«
Áö¿ªº° ÁÖ¿ä ±ÔÁ¦
Á¦5Àå ¼¼°èÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ¼ö¿ä ºÐ¼®
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸°³) ºÐ¼®, 2019-2023³â
ÇöÀç¿Í Àå·¡ ½ÃÀå ±Ô¸ð(100¸¸°³) ¿¹Ãø, 2024-2033³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Á¦6Àå ¼¼°èÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå-°¡°Ý ºÐ¼®
Á¦Ç° À¯Çüº° Áö¿ªº° °¡°Ý ºÐ¼®
°¡°Ý ºÐ¼®
Á¦Á¶¾÷ü ·¹º§ÀÇ °¡°Ý ¼³Á¤
À¯Åë¾÷ü ·¹º§ °¡°Ý ¼³Á¤
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
Á¦7Àå ¼¼°èÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ¼ö¿ä(±Ý¾× ¶Ç´Â ±Ô¸ð, 100¸¸ ´Þ·¯) ºÐ¼®
°ú°Å ½ÃÀå ¸ÅÃâ(100¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
ÇöÀç¿Í Àå·¡ ½ÃÀå ¸ÅÃâ(100¸¸ ´Þ·¯) ¿¹Ãø, 2024-2033³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë ¼öÀÍ ±âȸ
Á¦8Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
¹ë·ùüÀÎ
½ÃÀå ¿ªÇÐ
Á¦9Àå Á¦Ç° À¯Çüº° ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) Á¦Ç° À¯Çüº° ºÐ¼®, 2019-2023³â
ÇöÀç¿Í Àå·¡ ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, Á¦Ç° À¯Çüº°, 2024-2033³â
ÇÃ¶ó½ºÆ½ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®
±Ý¼Ó ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®
±Ý¼Ó ºñÇǺ¹ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®
ºÎºÐÀû ±Ý¼Ó ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®
±Ý¼Ó ¿ÏÀü ÇǺ¹ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®
Á¦Ç° À¯Çüº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦10Àå ¿ëµµº° ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿ëµµº° ºÐ¼®, 2019-2023³â
ÇöÀç¿Í Àå·¡ ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2033³â
¾ç¼º ´ãµµ ÇùÂø
´ãÁó ´©Ãâ
¾Ç¼º Æó»ö
´ã¼®
ÃéÀå¾Ï
¿ëµµº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦11Àå ÃÖÁ¾ »ç¿ëÀÚº° ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ÃÖÁ¾ »ç¿ëÀÚº° ºÐ¼®, 2019-2023³â
ÇöÀç¿Í Àå·¡ ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
º´¿ø
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
Àü¹® Ŭ¸®´Ð
ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦12Àå Áö¿ªº° ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
¼Ò°³
Áö¿ªº° ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ½ÇÀû ºÐ¼®, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í Áö¿ªº° ¼ö·® ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áö¿ªº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦13Àå ºÏ¹ÌÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
Á¦14Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
Á¦15Àå À¯·´ÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
Á¦16Àå ³²¾Æ½Ã¾ÆÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
Á¦17Àå µ¿¾Æ½Ã¾ÆÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
Á¦18Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
Á¦19Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
Á¦20Àå ½ÅÈï±¹¿¡¼ÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
¼Ò°³
ÁÖ¿ä ±¹°¡º° ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
¼¼°è¿Í ±¹°¡º° ¼ºÀå ºñ±³
Áß±¹ÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
¼Ò°³
°¡°Ý ºÐ¼®
PEST ºÐ¼®
½ÃÀå ºÐ·ù¿¡ ÀÇÇÑ ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° ½ÃÀå ±Ô¸ð(100¸¸°³)¿Í ±Ý¾×(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø
Á¦Ç° À¯Çüº°
ÃÖÁ¾ »ç¿ëÀÚº°
¿ëµµº°
Áß±¹ÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå-°æÀï ±¸µµ
Áß±¹-¹«¿ª ºÐ¼®
ÀεµÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
¼Ò°³
°¡°Ý ºÐ¼®
PEST ºÐ¼®
½ÃÀå ºÐ·ù¿¡ ÀÇÇÑ ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° ½ÃÀå ±Ô¸ð(100¸¸°³)¿Í ±Ý¾×(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø
Á¦Ç° À¯Çüº°
¿ëµµº°
ÃÖÁ¾ »ç¿ëÀÚº°
ÀεµÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå-°æÀï ±¸µµ
Àεµ-¹«¿ª ºÐ¼®
ºê¶óÁúÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå ºÐ¼®
¼Ò°³
°¡°Ý ºÐ¼®
PEST ºÐ¼®
½ÃÀå ºÐ·ù¿¡ ÀÇÇÑ ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° ½ÃÀå ±Ô¸ð(100¸¸°³)¿Í ±Ý¾×(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø
Á¦Ç° À¯Çüº°
ÃÖÁ¾ »ç¿ëÀÚº°
¿ëµµº°
ºê¶óÁúÀÇ ÃéÀå ¹× ´ãµµ ½ºÅÙÆ® ½ÃÀå-°æÀï ±¸µµ
ºê¶óÁú - ¹«¿ª ºÐ¼®
Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®
±â¾÷ Tierº° ½ÃÀå ºÐ¼®(ÃéÀå ¹× ´ãµµ ½ºÅÙÆ®)
½ÃÀå ÁýÁß
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀåÇöÀçºÐ¼®
Á¦22Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï¿¡ ÀÇÇÑ °¡°Ý ºÐ¼®
°æÀï º¥Ä¡¸¶Å·
°æÀïÀÇ »ó¼¼
Cook Medical Inc.
Boston Scientific Corporation
CONMED Corporation
Olympus Corporation
Medtronic Plc.
Taewoong Medical Co., Ltd.
ENDO-FLEX GmbH.
ELLA-CS, sro
Becton, Dickinson and Company
Abbott Laboratories
Á¦23Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú ¾à¾î
Á¦24Àå Á¶»ç ¹æ¹ý
JHS
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently released a comprehensive report on the global Pancreatic and Biliary Stents Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.
Key Insights:
Pancreatic and Biliary Stents Market Size (2024E): USD 410.14 Mn
Projected Market Value (2033F): USD 642.34 Mn
Global Market Growth Rate (CAGR 2024 to 2033): 5.1%
Pancreatic and Biliary Stents Market - Report Scope:
Pancreatic and biliary stents are medical devices used to relieve obstructions in the pancreatic and biliary ducts, typically caused by conditions such as tumors, pancreatitis, or gallstones. These stents are essential in managing various gastrointestinal disorders, improving patient outcomes, and enhancing the quality of life. The market is driven by the increasing prevalence of pancreatic and biliary diseases, advancements in stent technology, and the rising geriatric population prone to such health issues.
Market Growth Drivers:
Several key factors are driving the growth of the global Pancreatic and Biliary Stents Market. The rising incidence of pancreatic cancer and other gastrointestinal diseases necessitates effective treatment options, thereby propelling market demand. Additionally, advancements in endoscopic procedures and the development of innovative stent designs that offer improved patient comfort and effectiveness are further contributing to market growth. Increasing healthcare expenditure and the growing awareness of minimally invasive procedures also play significant roles in driving market expansion.
Market Restraints:
Despite its growth potential, the Pancreatic and Biliary Stents Market faces several challenges. Complications associated with stent placement, such as migration or blockage, can hinder market growth. Furthermore, the high cost of advanced stent technologies may limit their accessibility in developing regions. Regulatory hurdles and the need for extensive clinical validation can also pose barriers to market entry for new players.
Market Opportunities:
The Pancreatic and Biliary Stents Market presents substantial growth opportunities, particularly with ongoing innovations in stent materials and designs that enhance safety and efficacy. The increasing demand for minimally invasive procedures in gastroenterology is creating new avenues for the development of advanced stenting solutions. Collaborations between manufacturers and healthcare providers can drive product development and improve patient outcomes. Additionally, the growing trend of personalized medicine and targeted therapies in gastrointestinal diseases offers further opportunities for market growth.
Key Questions Answered in the Report:
What are the primary factors driving the global Pancreatic and Biliary Stents Market?
Which regions are witnessing the highest adoption of pancreatic and biliary stents, and what trends are influencing this?
How are advancements in endoscopic techniques impacting the competitive landscape of stent usage?
Who are the leading players in the Pancreatic and Biliary Stents Market, and what strategies are they implementing to maintain their market positions?
What are the emerging trends and future prospects in the global Pancreatic and Biliary Stents Market?
Competitive Intelligence and Business Strategy:
Leading players in the Pancreatic and Biliary Stents Market, including companies like Boston Scientific, Cook Medical, and Medtronic, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced stent designs that improve biocompatibility and reduce complications. Collaborations with healthcare professionals and research institutions are crucial for market penetration and sustained growth. Ensuring compliance with regulatory standards and promoting clinical research initiatives helps these companies maintain a competitive edge and achieve long-term success in the Pancreatic and Biliary Stents Market.
Key Companies Profiled:
Cook Medical Inc.
Boston Scientific Corporation
CONMED Corporation
Olympus Corporation
Medtronic Plc.
Taewoong Medical Co., Ltd.
ENDO-FLEX GmbH.
ELLA-CS, s.r.o
Becton, Dickinson and Company
Abbott Laboratories
Pancreatic and Biliary Stents Market Segments Covered in the Report
By Type
By Application
Biliopancreatic Leakages
Pancreatic Cancer
Benign Biliary Structures
Gallstones
By End-use
Hospitals
Ambulatory Surgical Centers
By Geography
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Procedure Adoption / Usage Analysis
4.2. Procedure USPs / Features
4.3. Promotional Strategies, By Key Manufacturers
4.4. Key Regulations, By Region
5. Global Pancreatic and Biliary Stents Market Demand Analysis 2019-2023 and Forecast, 2024-2033
5.1. Historical Market Volume (Mn Units) Analysis, 2019-2023
5.2. Current and Future Market Volume (Mn Units) Projections, 2024-2033
5.3. Y-o-Y Growth Trend Analysis
6. Global Pancreatic and Biliary Stents Market - Pricing Analysis
6.1. Regional Pricing Analysis By Product Type
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Pancreatic and Biliary Stents Market Demand (in Value or Size in US$ Mn ) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Mn ) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn ) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare Industry Outlook
8.2. Forecast Factors - Relevance & Impact
8.2.1. Adoption of Stenting technique
8.2.2. Cost of Pancreatic and Biliary Stents
8.2.3. Regulatory Imposition on Pancreatic and Biliary Stents
8.2.4. Advancements in Pancreatic and Biliary Stents Techniques
8.2.5. Incremental R&D by Product-Based Companies
8.3. Value Chain
8.4. Market Dynamics
8.4.1. Drivers
8.4.2. Restraints
8.4.3. Opportunity Analysis
9. Global Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn ) Analysis By Product Type, 2019-2023
9.3. Current and Future Market Size (US$ Mn ) & Volume Analysis and Forecast By Product Type, 2024-2033
9.3.1. Plastic Pancreatic and Biliary Stent
9.3.2. Metal Pancreatic and Biliary Stent
9.3.2.1. Metal Non-Covered Pancreatic and Biliary Stents
9.3.2.2. Metal Partially Covered Pancreatic and Biliary Stents
9.3.2.3. Metal Fully Covered Pancreatic and Biliary Stents
9.4. Market Attractiveness Analysis By Product Type
10. Global Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn ) Analysis By Application, 2019-2023
10.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Application, 2024-2033
10.3.1. Benign biliary strictures
10.3.2. Biliary leaks
10.3.3. Malignant obstruction
10.3.4. Biliary stones
10.3.5. Pancreatic cancer
10.4. Market Attractiveness Analysis By Application
11. Global Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn ) Analysis By End User, 2019-2023
11.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By End User, 2024-2033
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centres
11.3.3. Specialty Clinics
11.4. Market Attractiveness Analysis By End User
12. Global Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn ) Analysis By Region, 2019-2023
12.3. Current Market Size (US$ Mn ) & Volume Analysis and Forecast By Region, 2024-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn ) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2033
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.2. By Product Type
13.4.3. By Application
13.4.4. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Application
13.5.4. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Latin America Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn ) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2033
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product Type
14.4.3. By Application
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Application
14.5.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Europe Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn ) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2033
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. Italy
15.4.1.3. France
15.4.1.4. U.K.
15.4.1.5. Spain
15.4.1.6. BENELUX
15.4.1.7. Russia
15.4.1.8. Rest of Europe
15.4.2. By Product Type
15.4.3. By Application
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Application
15.5.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. South Asia Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn ) Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2033
16.4.1. By Country
16.4.1.1. India
16.4.1.2. Thailand
16.4.1.3. Indonesia
16.4.1.4. Malaysia
16.4.1.5. Rest of South Asia
16.4.2. By Product Type
16.4.3. By Application
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Application
16.5.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. East Asia Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn ) Trend Analysis By Market Taxonomy, 2019-2023
17.4. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2033
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.2. By Product Type
17.4.3. By Application
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Application
17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Oceania Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn ) Trend Analysis By Market Taxonomy, 2019-2023
18.4. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2033
18.4.1. By Country
18.4.1.1. Australia
18.4.1.2. New Zealand
18.4.2. By Product Type
18.4.3. By Application
18.4.4. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product Type
18.5.3. By Application
18.5.4. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn ) Trend Analysis By Market Taxonomy, 2019-2023
19.4. Market Size (US$ Mn ) & Volume Forecast By Market Taxonomy, 2024-2033
19.4.1. By Country
19.4.1.1. GCC Countries
19.4.1.2. Turkey
19.4.1.3. Northern Africa
19.4.1.4. South Africa
19.4.1.5. Rest of Middle East and Africa
19.4.2. By Product Type
19.4.3. By Application
19.4.4. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product Type
19.5.3. By Application
19.5.4. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Emerging Countries Pancreatic and Biliary Stents Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. China Pancreatic and Biliary Stents Market Analysis
20.2.1. Introduction
20.2.2. Pricing Analysis
20.2.3. PEST Analysis
20.2.4. Market Value Proportion Analysis by Market Taxonomy
20.2.5. Market Volume (Mn Units) and Value (US$ Mn ) Analysis and Forecast by Market Taxonomy
20.2.5.1. By Product Type
20.2.5.2. By End User
20.2.5.3. By Application
20.2.6. China Pancreatic and Biliary Stents Market - Competition Landscape
20.2.7. China - Trade Analysis
20.3. India Pancreatic and Biliary Stents Market Analysis
20.3.1. Introduction
20.3.2. Pricing Analysis
20.3.3. PEST Analysis
20.3.4. Market Value Proportion Analysis by Market Taxonomy
20.3.5. Market Volume (Mn Units) and Value (US$ Mn ) Analysis and Forecast by Market Taxonomy
20.3.5.1. By Product Type
20.3.5.2. By Application
20.3.5.3. By End User
20.3.6. India Pancreatic and Biliary Stents Market - Competition Landscape
20.3.7. India - Trade Analysis
20.4. Brazil Pancreatic and Biliary Stents Market Analysis
20.4.1. Introduction
20.4.2. Pricing Analysis
20.4.3. PEST Analysis
20.4.4. Market Value Proportion Analysis by Market Taxonomy
20.4.5. Market Volume (Mn Units) and Value (US$ Mn ) Analysis and Forecast by Market Taxonomy
20.4.5.1. By Product Type
20.4.5.2. By End User
20.4.5.3. By Application
20.4.6. Brazil Pancreatic and Biliary Stents Market - Competition Landscape
20.4.7. Brazil - Trade Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies ( Pancreatic and Biliary Stents)
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1. By Regional footprint of Players
21.4.2. Product foot print by Players
21.4.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Pricing Analysis by Competition
22.3. Competition Benchmarking
22.4. Competition Deep Dive
22.4.1. Cook Medical Inc.
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Profitability by Market Segments (Product/Channel/Region)
22.4.1.4. Sales Footprint
22.4.1.5. Strategy Overview
22.4.1.5.1. Marketing Strategy
22.4.1.5.2. Product Strategy
22.4.1.5.3. Channel Strategy
22.4.2. Boston Scientific Corporation
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Profitability by Market Segments (Product/Channel/Region)
22.4.2.4. Sales Footprint
22.4.2.5. Strategy Overview
22.4.2.5.1. Marketing Strategy
22.4.2.5.2. Product Strategy
22.4.2.5.3. Channel Strategy
22.4.3. CONMED Corporation
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Profitability by Market Segments (Product/Channel/Region)
22.4.3.4. Sales Footprint
22.4.3.5. Strategy Overview
22.4.3.5.1. Marketing Strategy
22.4.3.5.2. Product Strategy
22.4.3.5.3. Channel Strategy
22.4.4. Olympus Corporation
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Profitability by Market Segments (Product/Channel/Region)
22.4.4.4. Sales Footprint
22.4.4.5. Strategy Overview
22.4.4.5.1. Marketing Strategy
22.4.4.5.2. Product Strategy
22.4.4.5.3. Channel Strategy
22.4.5. Medtronic Plc.
22.4.5.1. Overview
22.4.5.2. Product Portfolio
22.4.5.3. Profitability by Market Segments (Product/Channel/Region)
22.4.5.4. Sales Footprint
22.4.5.5. Strategy Overview
22.4.5.5.1. Marketing Strategy
22.4.5.5.2. Product Strategy
22.4.5.5.3. Channel Strategy
22.4.6. Taewoong Medical Co., Ltd.
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Profitability by Market Segments (Product/Channel/Region)
22.4.6.4. Sales Footprint
22.4.6.5. Strategy Overview
22.4.6.5.1. Marketing Strategy
22.4.6.5.2. Product Strategy
22.4.6.5.3. Channel Strategy
22.4.7. ENDO-FLEX GmbH.
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Profitability by Market Segments (Product/Channel/Region)
22.4.7.4. Sales Footprint
22.4.7.5. Strategy Overview
22.4.7.5.1. Marketing Strategy
22.4.7.5.2. Product Strategy
22.4.7.5.3. Channel Strategy
22.4.8. ELLA-CS, s.r.o
22.4.8.1. Overview
22.4.8.2. Product Portfolio
22.4.8.3. Profitability by Market Segments (Product/Channel/Region)
22.4.8.4. Sales Footprint
22.4.8.5. Strategy Overview
22.4.8.5.1. Marketing Strategy
22.4.8.5.2. Product Strategy
22.4.8.5.3. Channel Strategy
22.4.9. Becton, Dickinson and Company
22.4.9.1. Overview
22.4.9.2. Product Portfolio
22.4.9.3. Profitability by Market Segments (Product/Channel/Region)
22.4.9.4. Sales Footprint
22.4.9.5. Strategy Overview
22.4.9.5.1. Marketing Strategy
22.4.9.5.2. Product Strategy
22.4.9.5.3. Channel Strategy
22.4.10. Abbott Laboratories
22.4.10.1. Overview
22.4.10.2. Product Portfolio
22.4.10.3. Profitability by Market Segments (Product/Channel/Region)
22.4.10.4. Sales Footprint
22.4.10.5. Strategy Overview
22.4.10.5.1. Marketing Strategy
22.4.10.5.2. Product Strategy
22.4.10.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
°ü·ÃÀÚ·á